Authors - Johnson, Marcou, Isaacs & Nix, LLC

Oct 8 2025

USPTO Update – Automated Search Pilot Program

By: Brent Nix

October 8, 2025

General

The USPTO takes another step in the direction of AI-assisted search with a new pilot program. Starting October 20, the […]...

General

Sep 29 2025

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

By: Brent Nix

September 29, 2025

Insights

UniCure announced positive 3-year data for their Huntington’s disease gene therapy this week, with the company receiving FDA...

Insights

Feb 28 2025

Navigating AI Patent Protection: Strategic Considerations for Biotech Companies

By: Brent Nix

February 28, 2025

General

As artificial intelligence (AI) continues transforming the biotechnology landscape, protecting AI-related innovations has become...

General

Aug 20 2024

Federal Circuit Clarifies Scope of Obviousness-Type Double Patenting After Curveball Thrown by In re Cellect

By: Brent Nix

August 20, 2024

Insights

In its 2023 decision in In re Cellect, the U.S. Court of Appeals for the Federal Circuit appeared to expand the […]...

Insights

Mar 28 2024

Unraveling the Power of Unity: Patent Pooling for Businesses

By: Brent Nix

March 28, 2024

Insights

In today’s fast-paced and innovative business landscape, understanding the intricate dynamics of patent law is crucial. One concept...

Insights

Posts by: F. Brent Nix, J.D., M.Sc.

USPTO Update – Automated Search Pilot Program

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

Navigating AI Patent Protection: Strategic Considerations for Biotech Companies

Federal Circuit Clarifies Scope of Obviousness-Type Double Patenting After Curveball Thrown by In re Cellect

Unraveling the Power of Unity: Patent Pooling for Businesses

Categories

Articles by Attorneys

Articles by Practices

Archives

Related Posts

Posts by: F. Brent Nix, J.D., M.Sc.

USPTO Update – Automated Search Pilot Program

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

Navigating AI Patent Protection: Strategic Considerations for Biotech Companies

Federal Circuit Clarifies Scope of Obviousness-Type Double Patenting After Curveball Thrown by In re Cellect

Unraveling the Power of Unity: Patent Pooling for Businesses

Share

Categories

Articles by Attorneys

Articles by Practices

Archives

Related Posts

subscribe

Subscribe to our newsletter